Anti-adipogenic effects of sesamol on human mesenchymal stem cells

Biochemical and Biophysical Research Communications

Volumn 469, Issue 1, 2016, Pages 49-54

  Kim, Min ^a   Lee, Yoo Jung ^a   Jee, Seung Cheol ^a   Choi, Inho ^b   Sung, Jung Suk ^a  

^a Dongguk University   (South Korea)

^b Hoseo University   (South Korea)

Author keywords

Adipogenesis; Human mesenchymal stem cells; Osteogenesis; Sesamol

Indexed keywords

ADIPONECTIN; AGENTS AFFECTING LIPID METABOLISM; GLYCEROL; HERMES ANTIGEN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHENOL DERIVATIVE; SESAME SEED OIL; SESAMOL; THY 1 ANTIGEN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; 1,3 BENZODIOXOLE DERIVATIVE; ANTIOXIDANT;

ADIPOCYTE; ADIPOGENESIS; ANTIOXIDANT ACTIVITY; ARTICLE; BONE DEVELOPMENT; CELL COUNT; CELL DIFFERENTIATION; CELL MATURATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; INTRACELLULAR SPACE; LIPID STORAGE; LIPOLYSIS; MESENCHYMAL STEM CELL; OSTEOBLAST; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; LIPID METABOLISM; MESENCHYMAL STROMA CELL; PHYSIOLOGY;

ADIPOCYTES; ADIPOGENESIS; ANTIOXIDANTS; BENZODIOXOLES; CELL DIFFERENTIATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIPID METABOLISM; MESENCHYMAL STROMAL CELLS; PHENOLS;

EID: 84950262496     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.11.070     Document Type: Article

References (41)

1. A. Sawant, D. Chanda, T. Isayeva, G. Tsuladze, W.T. Garvey, and S. Ponnazhagan Noggin is novel inducer of mesenchymal stem cell adipogenesis: implications for bone health and obesity J. Biol. Chem. 287 2012 12241 12249
2. J.J. Minguell, A. Erices, and P. Conget Mesenchymal stem cells Exp. Biol. Med. Maywood 226 2001 507 520
3. K. Sudo, M. Kanno, K. Miharada, S. Ogawa, T. Hiroyama, K. Saijo, and Y. Nakamura Mesenchymal progenitors able to differentiate into osteogenic, chondrogenic, and/or adipogenic cells in vitro are present in most primary fibroblast-like cell populations Stem Cells 25 2007 1610 1617
4. V.F. Vianna, D.C. Bonfim, S. Cavalcanti Ados, M.C. Fernandes, S.A. Kahn, P.L. Casado, I.C. Lima, S.S. Murray, E.J. Murray, and M.E. Duarte Late adherent human bone marrow stromal cells form bone and restore the hematopoietic microenvironment in vivo Biomed. Res. Int. 2013 2013 790842
5. C.J. Rosen, C. Ackert-Bicknell, J.P. Rodriguez, and A.M. Pino Marrow fat and the bone microenvironment: developmental, functional, and pathological implications Crit. Rev. Eukaryot. Gene Expr. 19 2009 109 124
6. J.M. Gimble, C.E. Robinson, X. Wu, and K.A. Kelly The function of adipocytes in the bone marrow stroma: an update Bone 19 1996 421 428
7. M.E. Nuttall, and J.M. Gimble Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications Curr. Opin. Pharmacol. 4 2004 290 294
8. O. Gurevitch, S. Slavin, I. Resnick, S. Khitrin, and A. Feldman Mesenchymal progenitor cells in red and yellow bone arrow Folia Biol. Praha 55 2009 27 34
9. J.M. Gimble, S. Zvonic, Z.E. Floyd, M. Kassem, and M.E. Nuttall Playing with bone and fat J. Cell Biochem. 98 2006 251 266
10. E.J. Moerman, K. Teng, D.A. Lipschitz, and B. Lecka-Czernik Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways Aging Cell 3 2004 379 389
11. B.B. Kahn, and J.S. Flier Obesity and insulin resistance J. Clin. Investig. 106 2000 473 481
12. J. Justesen, K. Stenderup, E.N. Ebbesen, L. Mosekilde, T. Steiniche, and M. Kassem Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis Biogerontology 2 2001 165 171
13. R. Burkhardt, G. Kettner, W. Bohm, M. Schmidmeier, R. Schlag, B. Frisch, B. Mallmann, W. Eisenmenger, and T. Gilg Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study Bone 8 1987 157 164
14. O. Naveiras, V. Nardi, P.L. Wenzel, P.V. Hauschka, F. Fahey, and G.Q. Daley Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment Nature 460 2009 259 263
15. P. Meunier, J. Aaron, C. Edouard, and G. Vignon Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies Clin. Orthop. Relat. Res. 80 1971 147 154
16. P. Minaire, C. Edouard, M. Arlot, and P.J. Meunier Marrow changes in paraplegic patients Calcif. Tissue Int. 36 1984 338 340
17. C.J. Rosen, and M.L. Bouxsein Mechanisms of disease: is osteoporosis the obesity of bone? Nat. Clin. Pract. Rheumatol. 2 2006 35 43
18. M.A. Bredella, C.M. Gill, A.V. Gerweck, M.G. Landa, V. Kumar, S.M. Daley, M. Torriani, and K.K. Miller Ectopic and serum lipid levels are positively associated with bone marrow fat in obesity Radiology 269 2013 534 541
19. M.W. Payne, H.K. Uhthoff, and G. Trudel Anemia of immobility: caused by adipocyte accumulation in bone marrow Med. Hypotheses 69 2007 778 786
20. L. Fajas, K. Schoonjans, L. Gelman, J.B. Kim, J. Najib, G. Martin, J.C. Fruchart, M. Briggs, B.M. Spiegelman, and J. Auwerx Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism Mol. Cell Biol. 19 1999 5495 5503
21. M.J. Jeon, J.A. Kim, S.H. Kwon, S.W. Kim, K.S. Park, S.W. Park, S.Y. Kim, and C.S. Shin Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts J. Biol. Chem. 278 2003 23270 23277
22. A.W. James Review of signaling pathways governing MSC osteogenic and adipogenic differentiation Sci. Cairo 2013 2013 684736
23. Y. Zuo, L. Qiang, and S.R. Farmer Activation of CCAAT/enhancer-binding protein (C/EBP) alpha expression by C/EBP beta during adipogenesis requires a peroxisome proliferator-activated receptor-gamma-associated repression of HDAC1 at the C/ebp alpha gene promoter J. Biol. Chem. 281 2006 7960 7967
24. T.M. Larsen, S. Toubro, and A. Astrup PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? Int. J. Obes. Relat. Metab. Disord. 27 2003 147 161
25. B. Desvergne, L. Michalik, and W. Wahli Transcriptional regulation of metabolism Physiol. Rev. 86 2006 465 514
26. I.D. Platt, and A. El-Sohemy Regulation of osteoblast and adipocyte differentiation from human mesenchymal stem cells by conjugated linoleic acid J. Nutr. Biochem. 20 2009 956 964
27. W.H. Yu, F.G. Li, X.Y. Chen, J.T. Li, Y.H. Wu, L.H. Huang, Z. Wang, P. Li, T. Wang, B.T. Lahn, and A.P. Xiang PPARgamma suppression inhibits adipogenesis but does not promote osteogenesis of human mesenchymal stem cells Int. J. Biochem. Cell. Biol. 44 2012 377 384
28. L. Zhang, P. Su, C. Xu, C. Chen, A. Liang, K. Du, Y. Peng, and D. Huang Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARgamma expression and enhancing Runx2 expression J. Pineal Res. 49 2010 364 372
29. Q. Gu, Y. Cai, C. Huang, Q. Shi, and H. Yang Curcumin increases rat mesenchymal stem cell osteoblast differentiation but inhibits adipocyte differentiation Pharmacogn. Mag. 8 2012 202 208
30. F. Bost, L. Caron, I. Marchetti, C. Dani, Y. Le Marchand-Brustel, and B. Binetruy Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage Biochem. J. 361 2002 621 627
31. S.Y. Gwon, J.Y. Ahn, C.H. Jung, B.K. Moon, and T.Y. Ha Shikonin suppresses ERK 1/2 phosphorylation during the early stages of adipocyte differentiation in 3T3-L1 cells BMC Complement. Altern. Med. 13 2013 207
32. F. Bost, M. Aouadi, L. Caron, and B. Binetruy The role of MAPKs in adipocyte differentiation and obesity Biochimie 87 2005 51 56
33. Z. Qiu, Y. Wei, N. Chen, M. Jiang, J. Wu, and K. Liao DNA synthesis and mitotic clonal expansion is not a required step for 3T3-L1 preadipocyte differentiation into adipocytes J. Biol. Chem. 276 2001 11988 11995
34. A. Kuhad, and K. Chopra Effect of sesamol on diabetes-associated cognitive decline in rats Exp. Brain Res. 185 2008 411 420
35. D.Z. Hsu, Y.W. Chen, P.Y. Chu, S. Periasamy, and M.Y. Liu Protective effect of 3,4-methylenedioxyphenol (sesamol) on stress-related mucosal disease in rats Biomed. Res. Int. 2013 2013 481827
36. M. Uchida, S. Nakajin, S. Toyoshima, and M. Shinoda Antioxidative effect of sesamol and related compounds on lipid peroxidation Biol. Pharm. Bull. 19 1996 623 626
37. S.R. Farmer Regulation of PPARgamma activity during adipogenesis Int. J. Obes. Lond. 29 Suppl. 1 2005 S13 S16
38. J.R. Jones, C. Barrick, K.A. Kim, J. Lindner, B. Blondeau, Y. Fujimoto, M. Shiota, R.A. Kesterson, B.B. Kahn, and M.A. Magnuson Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance Proc. Natl. Acad. Sci. U. S. A. 102 2005 6207 6212
39. Z. Wu, E.D. Rosen, R. Brun, S. Hauser, G. Adelmant, A.E. Troy, C. McKeon, G.J. Darlington, and B.M. Spiegelman Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity Mol. Cell 3 1999 151 158
40. J. Li, A. Nanayakkara, J. Jun, V. Savransky, and V.Y. Polotsky Effect of deficiency in SREBP cleavage-activating protein on lipid metabolism during intermittent hypoxia Physiol. Genom. 31 2007 273 280
41. F. Bost, M. Aouadi, L. Caron, P. Even, N. Belmonte, M. Prot, C. Dani, P. Hofman, G. Pages, J. Pouyssegur, Y. Le Marchand-Brustel, and B. Binetruy The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis Diabetes 54 2005 402 411